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ABSTRACT
Sequence analysis of the pbp genes from 20 Streptococcus pneumoniae isolates from Turkey (eight with
high-level penicillin-resistance, nine with low-level penicillin-resistance, and three that were penicillin-
susceptible) was performed and phylogenetic trees were constructed. Most isolates clustered together
within a single branch that was distinct from sequences deposited previously in GenBank, which
suggests that these isolates have probably evolved following new recombination events. The most
prominent active-site mutations, which have also been associated previously with resistance, were
T371A in PBP1a, E481G followed by T451A in PBP2b, and T338A in PBP2x. All isolates also possessed a
570SVES ⁄TK574 block in the PBP2b sequence, instead of the QLQPT sequence of R6, which is fairly
uncommon in GenBank sequences. This is the ﬁrst study to analyse alterations in the pbp sequences of
pneumococci isolated in Turkey.
Keywords pbp mutations, penicillin-non-susceptible pneumococci, penicillin resistance, sequence analysis,
Streptococcus pneumoniae
Original submission: 17 May 2005; Revised submission: 21 June 2005; Accepted: 1 August 2005
Clin Microbiol Infect 2006; 12: 150–155
INTRODUCTION
Penicillins and cephalosporins inhibit bacteria by
targeting the penicillin-binding proteins (PBPs)
that play a role in cell-wall synthesis [1–8]. PBPs
are transpeptidases and carboxypeptidases, with
a central transpeptidase domain ﬂanked by
N-terminal and carboxy-terminal regions. The
transpeptidase region includes the nucleophylic
serine (Ser37) and is responsible for cross-linking
of peptidoglycan. It is also the region at which the
active site of the enzyme is located. In all PBPs,
the penicillin-binding domain (PBD) in the
transpeptidase site includes three restricted mo-
tifs, the SXXK sequence, which has a penicillin-
binding serine, and SXN and KT(S)G triple motifs
[7–9]. Penicillins have been used for the treatment
of pneumococcal infections for more than ﬁve
decades. Unfortunately, this has resulted in the
emergence and spread of resistant clones world-
wide. Mutations in pbp1a, pbp2b and pbp2x are the
most important markers of penicillin resistance in
Streptococcus pneumoniae [10–12].
In recent studies, the prevalence of low- and
high-level penicillin resistance amongst pneumo-
coccal isolates from Turkey has been reported as
29–41.5% and 3–8%, respectively [13–16]. As no
data had been published previously concerning
alterations in the pbp genes of isolates fromTurkey,
the present study investigated themutations in the
active site of the pbp1a, 2b and 2xgenes inpenicillin-
non-susceptible S. pneumoniae isolates collected in
Turkey during the period 1997–2001.
MATERIALS AND METHODS
Bacterial isolates
Twenty isolates of S. pneumoniae, eight with high-level peni-
cillin resistance (PenR), nine with low-level penicillin resist-
ance (PenI), and three that were penicillin-susceptible (PenS),
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were selected randomly from 110 isolates collected between
1997 and 2001. There was no signiﬁcant clonal relationship
among these isolates on the basis of BOX-PCR results obtained
using the BOX A1R primer and the protocol of the Pneumo-
coccal Molecular Epidemiology Network (PMEN) [17]. The
serotypes and penicillin MICs for the isolates are shown in
Table 1.
DNA extraction, PCR and DNA sequencing
DNA extraction and PCR for the pbp genes were performed as
described previously [18]. The primers used for PCR and
sequence analysis are shown in Table 2. Ampliﬁcation prod-
ucts were puriﬁed with a QIAquick PCR Puriﬁcation Kit
(Qiagen, Valencia, CA, USA). Nucleotide sequence analysis
was performed on single strands using a Big Dye Terminator
Kit (Applied Biosystems, Foster City, CA, USA). The sequen-
cing reactions were cleaned using Centrisep spin columns
(Princeton Separations, Adelphia, NJ, USA) and analysed on
an ABI Prism 377 DNA sequencer (Applied Biosystems).
Phylogenetic analysis
The pbp1a, pbp2b and pbp2x active site sequences from the
isolates studied (nine pbp1a, 14 pbp2b, ten pbp2x) were aligned,
together with 20 pbp1a, 43 pbp2b and 38 pbp2x sequences from
GenBank, with Clustal X v.1.81. Phylogenetic trees of aligned
sequences were constructed with Mega v.2.1, using the
neighbour-joining method and Kimura-2 parameter correction
[19]. CIs of the tree were calculated by bootstrap analysis.
Synonymous (KS) and non-synonymous (KA) mutation rates
and KA ⁄KS values, as well as transition ⁄ transversion ratios for
all the isolates, were determined with Mega v.2.1.
Complete DNA sequences of pbp1a, pbp2b and pbp2x were
determined and phylogenetic trees were constructed for ﬁve,
14 and seven study isolates, respectively. The GenBank
sequences used for the phylogenetic trees and the correspond-
ing references are available in Table S1 (see Supplementary
Material).
RESULTS AND DISCUSSION
Active site mutations in the pbp1a, pbp2b and
pbp2x genes
T371A in the active site STMK motif, which has
been described previously as being important
for resistance, was the most prominent mutation
within the conserved sequence motifs of pbp1a.
This alteration, and a P432T mutation, was
detected in all PenI ⁄R isolates; identical muta-
tions have been reported previously [20,21]. As
the T371A mutation is adjacent to the serine
amino-acid in the SXXN motif of the penicillin-
binding region, this change modiﬁes the active
site and lowers the binding afﬁnity to penicillin.
However, as the P432T mutation is close to the
428SRN430 motif, it also affects binding to peni-
cillin. A 574NTGY577 block, instead of the TSQF
sequence of R6, was also detected in ﬁve
isolates (Fig. S1; see Supplementary Material).
This substitution has also been reported by
other investigators [20,22], and Smith and Klug-
man [23] have demonstrated the importance of
mutations at positions 574–577.
T451A (T252A) and E481G (E282G) mutations
were found in the pbp2b sequences from 92% of
the PenI ⁄R isolates, and these mutations have also
been reported previously [10,21,24]. Dowson et al.
[24] reported six or seven amino-acid substitu-
tions between T431 ⁄Q432-F437 of the pbp2b
sequence from mutants of PenI ⁄R S. pneumoniae
isolates. An additional T451A mutation, adjacent
to the 448SSN450 motif, has been shown to decrease
the binding afﬁnity of PBP2b to penicillin. Other
active site mutations detected in PenI ⁄R isolates
Table 1. Serotypes and penicillin MICs for the isolates
from Turkey
Isolate number MIC (mg ⁄L) Serotype Isolation date
6 2 9 V 17.11.1997
10 0.50 23F 04.05.1999
12 0.125 15 30.11.1999
16 2 9 V 18.10.2000
26 0.50 9 V 25.07.2000
28 1 14 08.04.1999
34 0.19 23 19.01.2000
35 2 15B 26.06.1997
44 1.5 14 15.12.2000
45 3 15B 21.11.2000
51 2 23 10.05.1999
64 1.5 23F 18.12.2000
78 0.50 9 V 15.02.1999
81 1 19 10.07.1999
82 0.38 23F 14.12.1999
83 1.5 23F 25.10.1999
88 0.25 14 12.05.2000
102 0.016 9 04.10.2000
105 0.016 3 21.12.2000
110 0.08 7 06.01.2001
Table 2. Primers used for PCR and nucleotide sequence
analysis
Primer Sequence
PBP1a 1(P) CGGCATTC GATTTGATTCGCTTCT
PBP1a 2(P) CTGAGAAGATGTCTTCTCAGG
PBP1a F1(S) ATGAACAAACCAACGATTCTG
PBP1a F2(S) GCTTGGTTAGCGATTCAGTTAG
PBP1a F3(S) AATGTAGACCAAGAAGCTC
PBP1a F4(S) GGTCTTGGTATCGACTATC
PBP1a F5(S) AATCGTTTAACTCCTATCG
PBP2b 1(P) ATCCT CTAAATGATTCTCAGG TGG
PBP2b 2(P) CAATTAGCTTAGCAATAGGTGTTGG
PBP2b F1(S) GATCCTCTAAATGATTCTCAGGTGG
PBP2b F2(S) AAGGTGTCTATGCAGTCGC
PBP2b F3(S) CATTGACCTTCCAGATGAGTC
PBP2b F4(S) GCTAACAATACTAATGCTG
PBP2x F1(P,S) CGTGGGACTATTTATGACCGAAATGG
PBP2x F2(S) CTTGCAGGGACAGACGGC
PBP2x F3(S) AATGAAGGATTGACTGGTG
PBP2x F4(S) ATGTATAACCACAGCACAG
PBP2x R1(P,S) AATTCCAGCACTGATGGAAATAAACATATTA
(P), PCR primer; (S), sequencing primer.
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were T494A and L460I. All isolates also pos-
sessed a SVES ⁄TK block between amino-acids
570 and 574, instead of the QLQPT sequence of
R6 (Fig. S2; see Supplementary Material). The
same mosaic genes have also been reported in
some strains from Iceland [25]. As one of the
PenS isolates also had the same changes, this
alteration does not seem to cause penicillin
resistance. Nevertheless, the block is located in
the active site and may affect the decrease in
penicillin susceptibility associated with other
mutations located in the active site, or it may
simply be a molecular evolution marker forming
part of a mosaic sequence acquired via homol-
ogous recombination by the Turkish isolates in
the present study.
Analysis of the pbp2x genes revealed a T338A
alteration in the 337STMK340 motif in three of
seven PenI ⁄R isolates. Another two isolates had an
alteration of T338P, indicating positive Darwinian
selection under antibiotic pressure. An A369V
mutation was found exclusively in ﬁve PenI ⁄R
isolates. Four isolates, including a PenS strain, also
possessed a Q552E change located near the
547KSG549 box (Fig. S3; see Supplementary
Material). T338A ⁄P and Q552E mutations have
also been reported in previous studies [11,21,26].
As these mutations take place near the active site,
or just on its periphery, they may change the
conﬁguration of the active site and cause drug
resistance by the same mechanism as the other
mutations mentioned above.
In PBP2x of S. pneumoniae, one of the basic
amino-acids that plays a role in penicillin resist-
ance is T338 in the STMK motif, located in the
primary part of the a2 helix. This amino-acid is
situated next to the serine to which the antibiotic
binds, and is located in a cavity separated from
the active site by the main chain (a3) of the
protein. This cavity also includes a water mole-
cule that is essential for acylation and deacylation
of b-lactams. The water molecule forms hydrogen
bonds with OH– groups of the T338, S571 and
Y536 amino-acids [11]. As a result of T338A
alteration, the rate of acylation is reduced. Mouz
et al. [26] showed that a T338A ⁄G ⁄P ⁄V substitu-
tion in the SXXK restricted motif changed the
location of the water molecule in the active site
(because of the absence of the OH– group),
leading to difﬁculty in binding of PBP2x to
b-lactams. The T338A mutation causes a decrease
in the b-lactam-binding afﬁnity of PBP2x greater
than that caused by T338G and T338P mutations.
Besides these mutations, S571A ⁄P and Y536F
mutations also lead to a decrease in afﬁnity
because of the absence of the OH– group in
mutant amino-acids.
One of the major amino-acids in PBP2x that
plays a role in penicillin resistance is Q552, which
is often different in penicillin-resistant strains.
This amino-acid is situated close to the 547KSG549
restricted motif. Gln552 is a positively-charged
molecule, whereas E is negatively-charged. This
substitution changes the acylation activity of
PBP2x by two- or three-fold [26]. In strains
carrying T338A and Q552E mutations together,
the afﬁnity of PBP2x for penicillin and cefotaxime
is decreased by 90% and 80%, respectively
[11,26]. Furthermore, the b-lactam afﬁnities of
strains carrying triple mutations of T338A, Q552E
and S571P were signiﬁcantly lower [26]. How-
ever, in the present study, no increase was
observed in the b-lactam MICs for the two isolates
(numbers 12 and 82) that carried double muta-
tions in comparison with isolates carrying a single
mutation. In addition, two isolates (numbers 45,
penicillin MIC of 3 mg ⁄L, and 88, penicillin MIC
of 0.25 mg ⁄L) were penicillin-resistant although
they lacked these mutations. The combined effects
of other genes (i.e., pbp genes other than pbp1a,
pbp2b, pbp2x and the murMN operon) have also
been shown to be important for the expression of
PenI or PenR [27–31], and this may be the case for
the isolates in the present study.
Overall, when the active site mutations were
considered in association with penicillin MICs,
the results from the present study were compat-
ible with the suggestion that pbp1a mutations are
of greatest importance for PenR.
Phylogenetic analysis of pbp genes
Phylogenetic trees based on the pbp sequences
indicated that most Turkish isolates clustered
together, with high bootstrap values of > 80 for
pbp1a (Fig. 1) and pbp2x (Fig. S4; see Supplement-
ary Material), and of 69–100 for pbp2b (Fig. S5; see
Supplementary Material) in a branch separate
from the published GenBank sequences. This was
especially the case for pbp1a. This ﬁnding suggests
that different recombination events have occurred
in these isolates. Two other sequences reported
for isolates from France and Iceland were also on
the same branch as the pbp1a sequences for the
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isolates from Turkey. In particular, sequences
from isolates 6, 26, 44 and 64 were very similar
to those from the isolates from France and
Iceland. However, similarity in only one gene
may not be sufﬁcient to prove an evolutionary
relationship among these isolates. In the phylo-
genetic tree drawn using the pbp2b sequences,
the isolates from Turkey also clustered within a
branch that was separate from the GenBank
sequences, with the exception of isolate 82,
which was located on the same branch as the
isolates from France and Iceland. No epidemi-
ological connection was found between these
countries and the patient from whom isolate 82
was cultivated.
In terms of branch length, the tree topologies
suggest that the PBPs of the Turkish isolates have
evolved in a local geographical niche, with pbp1a
showing evidence of more recent recombination
processes than the sequences obtained from Gen-
Bank.
Variation analysis of nucleotide and amino-acid
sequences
Variation analysis showed that the pbp sequences
of the isolates in the present study were similar at
both the nucleotide and amino-acid level (mean
divergence of nucleotide bases was 0.6%, 6.6%
and 7.8% for pbp1a, pbp2b and pbp2x, respect-
ively). This is probably the result of the same
environmental factors acting on these isolates,
and recovery of the isolates from the same
geographical area with similar commensal strep-
tococci.
When compared with the sequences of R6, the
nucleotide and peptide sequences of PenI ⁄R iso-
lates showed up to 14.9% and 8.5% divergence,
respectively. Moreover, a 406-bp region (1726–
2131) of the pbp2b sequence, which is 32.7%
divergent from the R6 homologue, showed 97%
similarity to the pbp2b sequence of Streptococcus
mitis. This supports the hypothesis that mosaic
 gi|26|
 gi|64|
 gi|6563346|gb|AF210750.1|AF210
 gi|44|
 gi|5410456|gb|AF139883.1|AF139
 gi|6|
 gi|28|
 gi|5726354|gb|AF159448.1|AF159
 gi|5410468|gb|AF139889.1|AF139
 gi|5410466|gb|AF139888.1|AF139
 gi|5410470|gb|AF139890.1|AF139
 gi|5410464|gb|AF139887.1|AF139
 gi|5410458|gb|AF139884.1|AF139
 gi|5410462|gb|AF139886.1|AF139
 gi|5410460|gb|AF139885.1|AF139
 gi|6563348|gb|AF210751.1|AF210
 gi|6563344|gb|AF210749.1|AF210
 gi|6563340|gb|AF210747.1|AF210
 gi|984230|emb|Z49095.1|SPCS111
 gi|984228|emb|Z49094.1|SPCS109
 gi|6563342|gb|AF210748.1|AF210
 gi|6563350|gb|AF210752.1|AF210
 gi|6563336|gb|AF210745.1|AF210
 gi|153766|gb|M90527.1|STRPONA **
 gi|6563338|gb|AF210746.1|AF21055
100
100
100
59
75
100
100
100
97
86
100
81
100
95
0.02 
Fig. 1. Phylogenetic tree, obtained by the neighbour-joining method and Kimura-2 parameter correction, for the
Streptococcus pneumoniae 1995-bp pbpla sequences (the frame marks the isolates from Turkey). Bootstrap values are shown
on the tree. **pbpla sequence of R6.
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genes acquired from commensal streptococci by
homologous recombination are responsible for
penicillin resistance in pneumococci.
Analysis of locus changes among the pbp1a,
pbp2b and pbp2x sequences
When KS and KA mutations were investigated for
the Turkish isolates and the GenBank sequences,
the proportion of KS mutations was, as expected,
higher (Table 3). This ﬁnding indicates that muta-
tions in pbp genes are KS mutations that do not
alter the amino-acid sequence, indicating that the
gene is functional and probably vital for the
microorganism [32,33]. Thus, the present ﬁndings
support the theory that the mutations result only
in the development of penicillin resistance, as
opposed to enzymic changes in the PBP proteins,
which are essential for peptidoglycan synthesis.
KA ⁄KS values of the pneumococcal sequences
from GenBank were similar for pbp2b and pbp2x.
A higher KA ⁄KS ratio for pbp1a shows that pbp1a
has been differentiating within itself [34]. More-
over, a higher KA ⁄KS ratio for pbp1a than for pbp2x
and pbp2b suggests that pbp1a may be less vital
functionally in comparison with pbp2x and pbp2b.
Previous studies have proved that PBP2X and
PBP2B are essential for cellular function, but that
PBP1A is non-essential [22,35]. However, the
small number of isolates examined in the present
study, and the choice of pbp genes for evolution-
ary analysis, may have affected the results. In
previous studies on genes related to resistance
and virulence, analysis of clinical isolates (which
are more virulent and resistant) has resulted in a
bias; therefore, commensal isolates are preferred
for phylogenetic analysis [32].
GenBank accession numbers
GenBank accession numbers of the sequences
determined in this study for pbp1a, pbp2b and
pbp2x are as follows: pbp1a: 6, AY937241; 26,
AY943313; 28, AY943314; 44, AY943315; 64,
AY943316; 78, DQ060831; 82, DQ060832; 83,
DQ060833; 110, DQ060834; pbp2b: 6, AY970297;
10, AY970298; 12, AY970299; 26, AY970300; 28,
AY970301; 34, AY970302; 35, AY970303; 44,
AY970304; 51, AY970305; 64: AY970306; 78,
AY970307; 81, AY970308; 82, AY970309; 110,
AY970310; pbp2x: 6, DQ020579; 10, DQ020580;
12, DQ020581; 34, DQ020582; 45, DQ020583; 82,
DQ020584; 88, DQ020585; 102, DQ020586; 105,
DQ020587; 110, DQ020588.
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